BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1052 related articles for article (PubMed ID: 18600484)

  • 1. Vogt-koyanagi-harada syndrome.
    Fang W; Yang P
    Curr Eye Res; 2008 Jul; 33(7):517-23. PubMed ID: 18600484
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prevalence, clinical characteristics, and causes of vision loss in children with Vogt-Koyanagi-Harada disease in South India.
    Martin TD; Rathinam SR; Cunningham ET
    Retina; 2010; 30(7):1113-21. PubMed ID: 20168275
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Vogt-Koyanagi-Harada disease.
    Damico FM; Kiss S; Young LH
    Semin Ophthalmol; 2005; 20(3):183-90. PubMed ID: 16282153
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Vogt-Koyanagi-Harada syndrome: review of clinical features.
    Pan D; Hirose T
    Semin Ophthalmol; 2011; 26(4-5):312-5. PubMed ID: 21958180
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Vogt-Koyanagi-Harada syndrome: importance of rapid diagnosis and therapeutic intervention].
    Bouchenaki N; Morisod L; Herbort CP
    Klin Monbl Augenheilkd; 2000 May; 216(5):290-4. PubMed ID: 10863695
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Vitiligo as a First Sign of Vogt-Koyanagi-Harada Disease.
    Vukojević M; Vukojevic N; Vuković A; Rupčić B; Blažević M; Blažević A
    Acta Dermatovenerol Croat; 2023 Dec; 31(4):229-231. PubMed ID: 38651852
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Vogt-Koyanagi-Harada syndrome in children: report of a case and review of the literature.
    Berker N; Ozdamar Y; Soykan E; Ozdal P; Ozkan SS
    Ocul Immunol Inflamm; 2007; 15(4):351-7. PubMed ID: 17763135
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Vogt-Koyanagi-Harada syndrome complicating allogeneic bone marrow transplantation.
    Pettitt AR; Neoh C; Wong SH; Clark RE
    Bone Marrow Transplant; 1994 Feb; 13(2):225-7. PubMed ID: 8205096
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Vogt-Koyanagi-Harada disease].
    Kjeka O; Krohn J
    Tidsskr Nor Laegeforen; 2005 Aug; 125(16):2195-7. PubMed ID: 16138134
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Therapeutic regimen in Vogt-Koyanagi-Harada syndrome].
    Yang P; Wang H; Zhou H; Zhong H; Li F; Huang X; Zhong H; Fu T
    Zhonghua Yan Ke Za Zhi; 2002 Apr; 38(4):196-9. PubMed ID: 12133384
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Progresses and existed problems on the diagnosis and treatment of Vogt-Koyanagi-Harada disease].
    Zheng YZ
    Zhonghua Yan Ke Za Zhi; 2012 Jun; 48(6):572-6. PubMed ID: 22943816
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Triple agent immunosuppressive therapy in Vogt-Koyanagi-Harada syndrome.
    Agarwal M; Ganesh SK; Biswas J
    Ocul Immunol Inflamm; 2006 Dec; 14(6):333-9. PubMed ID: 17162603
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Vogt Koyanagi Harada disease: treatment and visual prognosis.
    Alam M; Iqbal M; Khan BS; Hussain I
    J Coll Physicians Surg Pak; 2013 Oct; 23(10):740-2. PubMed ID: 24112262
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Vogt-Koyanagi-Harada disease].
    Bonnet C; Daudin JB; Monnet D; Brézin A
    J Fr Ophtalmol; 2017 Jun; 40(6):512-519. PubMed ID: 28579215
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Intravenous immunoglobulin therapy in Vogt-Koyanagi-Harada syndrome].
    González-Delgado M; González C; Blázquez JI; Salas-Puig J; Castro J; Hernández-Lahoz C
    Neurologia; 2004 Sep; 19(7):401-3. PubMed ID: 15273890
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Vogt-Koyanagi-Harada disease: Novel insights into pathophysiology, diagnosis and treatment.
    Du L; Kijlstra A; Yang P
    Prog Retin Eye Res; 2016 May; 52():84-111. PubMed ID: 26875727
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Vogt-Koyanagi-Harada syndrome in children].
    Laghmari M; Karim A; Ibrahimy W; Essakalli NH; Mohcine Z
    J Fr Ophtalmol; 2002 Jun; 25(6):636-40. PubMed ID: 12223954
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [The Vogt-Koyanagi-Harada syndrome in 11-year-old girl].
    Swiech-Zubilewicz A; Wróblewska E; Mańkowska A
    Klin Oczna; 2005; 107(7-9):511-4. PubMed ID: 16417010
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Inhibitory effect of Cyclosporin A and corticosteroids on the production of IFN-gamma and IL-17 by T cells in Vogt-Koyanagi-Harada syndrome.
    Liu X; Yang P; Lin X; Ren X; Zhou H; Huang X; Chi W; Kijlstra A; Chen L
    Clin Immunol; 2009 May; 131(2):333-42. PubMed ID: 19200788
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Vogt-Koyanagi-Harada disease.
    Read RW
    Ophthalmol Clin North Am; 2002 Sep; 15(3):333-41, vii. PubMed ID: 12434482
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 53.